Cellebrite (CLBT) CRO sells 383 shares to cover RSU tax obligations

Rhea-AI Filing Summary

Cellebrite DI Ltd. Global Chief Revenue Officer Marcus Jewell reported an open-market sale of 383 ordinary shares at a weighted average price of $13.01 per share. The footnotes explain the disposition is associated with tax obligations arising from the vesting of previously granted restricted stock units. Following this transaction, Jewell directly holds 452,759 ordinary shares.

Insider Trade Summary

Net Seller: 383 shares ($4,983)

Net Sell 1 txn

Insider Jewell Marcus

Role Global Chief Revenue Officer

Sold 383 shs ($5K)

Type	Security	Shares	Price	Value
Sale	Ordinary shares, par value NIS 0.00001	383	$13.01	$5K

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 452,759 shares (Direct, null)

Footnotes (1)

1. The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.84 to $13.175, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 383 shares Weighted average sale price: $13.01 per share Post-transaction holdings: 452,759 shares +2 more

5 metrics

Shares sold 383 shares Open-market sale on 2026-05-12

Weighted average sale price $13.01 per share Ordinary shares, par value NIS 0.00001

Post-transaction holdings 452,759 shares Direct ownership after reported sale

Trade price range $12.84–$13.175 per share Multiple transactions within this range

RSU grant date February 11, 2025 RSUs whose vesting led to tax-related disposition

Key Terms

restricted stock units ("RSUs"), weighted average price, open-market sale, tax obligations

4 terms

restricted stock units ("RSUs") financial

"The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

tax obligations financial

"The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jewell Marcus

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Chief Revenue Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	05/12/2026		S		383(1)	D	$13.01(2)	452,759	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.84 to $13.175, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Marcus Jewell	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cellebrite (CLBT) report for Marcus Jewell?

Cellebrite reported that Global Chief Revenue Officer Marcus Jewell sold 383 ordinary shares. The sale was an open-market transaction and is described as being associated with tax obligations from the vesting of restricted stock units previously granted to him.

At what price did Marcus Jewell sell Cellebrite (CLBT) shares?

The filing shows a weighted average sale price of $13.01 per share. Footnotes add that individual trades occurred in a range from $12.84 to $13.175, and detailed trade-by-trade pricing information is available to interested parties upon request.

How many Cellebrite (CLBT) shares does Marcus Jewell hold after this sale?

After selling 383 ordinary shares, Marcus Jewell directly holds 452,759 Cellebrite shares. This context shows the reported sale represents a very small portion of his total reported direct holdings in the company following the transaction.

Why is the Marcus Jewell Cellebrite (CLBT) share sale linked to RSU taxes?

Footnotes state the disposed shares were originally granted as restricted stock units on February 11, 2025. The disposition is associated with tax obligations triggered when those RSUs vested, indicating the sale is tied to covering tax liabilities rather than a discretionary portfolio shift.

Were Marcus Jewell’s Cellebrite (CLBT) share sales part of multiple trades?

Yes. The filing notes the reported weighted average price reflects multiple transactions. Shares were sold in separate trades within a price range of $12.84 to $13.175, and the insider has agreed to provide detailed breakdowns of each trade upon request.